期刊文献+

细菌性乳腺炎患者临床病原菌分析及诊治对策 被引量:2

Clinical etiology of bacterial mastitis and its treatment countermeasures
原文传递
导出
摘要 目的分析细菌性乳腺炎患者病原菌分布及其耐药性现状,为临床合理使用抗菌药物提供参考依据。方法收集医院2010年1月-2011年12月细菌性乳腺炎患者的脓液标本进行细菌培养及药敏试验。结果 124例标本病原菌的分离率为47.6%,以金黄色葡萄球菌为主,占72.88%;金黄色葡萄球菌对青霉素、红霉素的耐药率分别为90.70%和76.74%,而对万古霉素、左氧氟沙星、四环素、磺胺甲噁唑/甲氧苄啶、呋喃妥因及苯唑西林等的耐药率均<20.00%;金黄色葡萄球菌中耐甲氧西林金黄色葡萄球菌(MRSA)检出率为20.93%,44.19%可产生β-内酰胺酶。结论细菌性乳腺炎以金黄色葡萄球菌检出率最高,对青霉素、红霉素有较高耐药性,可将苯唑西林作为治疗细菌性乳腺炎首选药物;应加强细菌培养及药敏检查,根据药敏结果合理使用抗菌药物。 OBJECTIVE To investigate the distribution and antimicrobial resistance of pathogens isolated from the patients with bacterial mastitis so as to provide reference for clinical reasonable use of antibiotics.METHODS The pus specimens were collected from the patients with bacterial mastitis from Jan 2010 to Dec 2011,the bacterial culture and the drug susceptibility testing were performed.RESULTS The isolation rate of the pathogenic bacteria from 124 specimens was 47.6%,Staphylococcus aureus(70.49%) was the main species isolated,the drug resistance rates of S.aureus to penicillin and erythromycin were 90.70% and 76.74%,the resistance rates of S.aureus were all below 20.00% to vancomycin,levofloxacin,acheomycin,sulfamethoxazole/trimethoprim,and furantoin and oxacillin;the detection rate of methicillin-resistant S.aureus(MRSA) among S.aureus strains was 20.93%,and 44.19% could produce beta-lactamase.CONCLUSION The major pathogen in S.aureus is the major species of pathogens to be detected to cause bacterial mastitis and is highly resistant to pencillin and erythmmycin,the oxacillin can be selected as the first line drug for bacterial mastitis;it is necessary to strengthen the bacterial culture and the drug susceptibility testing as well as to reasonably use antibiotics according to the drug susceptibility testing.
作者 张春杰
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第22期5035-5037,共3页 Chinese Journal of Nosocomiology
关键词 细菌性乳腺炎 金黄色葡萄球菌 耐药性 Bacteria mastitis Staphylococcus aureus Antimicrobial resistance
  • 相关文献

参考文献5

二级参考文献12

  • 1李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 2孙宏莉,王辉,陈民钧.甲氧西林耐药的金黄色葡萄球菌耐药性及分子流行病学调查[J].中华微生物学和免疫学杂志,2005,25(2):137-141. 被引量:61
  • 3朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 4National Committee of Clinical Laboratoy Standards. Performance standards for antimicrobial susceptibility testing[M]. Fourteenth informational supplement. NCCLS document M100-S14. Wayne, Pennsylvania: NCCLS, 2004.1-159.
  • 5萨姆布鲁克J,拉塞尔DW.分子克隆实验指南[M].黄培堂,译.第3版.北京:科学出版社,2007.
  • 6van der Zee A, Steer N, Thijssen E, et al. Use ot multienzyme multiplex PCR amplified fragment length polymorphism typing in analysis of outbreaks of multiresistant Klebsiella pneumoniae in an intensive care unit[J]. J Clin Microbiol, 2003,41 (2) : 798-802.
  • 7Sabine P, Klaus O, Constanze W. Longitudinal study of the molecular epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital[J]. J Clin Microbiol,2006, 44(12) :4297-4302.
  • 8Vriens M, Blok H, Fluit A, et al. Costs associated with a strict policy to eradicate methieillin-resistant Staphylococcus aureus in a Dutch University Medical Center:a 10-year survey[J]. Eur J Clin Microbiol Infect Dis,2002,21(11):782-786.
  • 9Shimada K, Terai T, Igari J, et al. Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics[J]. Jpn J Antibiot, 2002, 55 (5) : 537- 567.
  • 10CDC NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004[J]. Am J Infect Control, 2004,32 (8) :470 485.

共引文献334

同被引文献8

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部